Purchase Order 7571TE26P00063
Award Date 7/20/26
Potential Completion Date 7/19/27
Potential Value $90K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health, Office of Logistics and Acquisition Operations awarded a purchase order to Illumina, Inc. for an Illumina NextSeq 2000 next-generation sequencer valued at $290,700 on September 16, 2020, with completion by October 16, 2020. Performance occurs in San Diego, California. The procurement replaced aging sequencing equipment at the National Eye Institute to reduce reagent costs, repair downtime, and eliminate required fluidics washes on the existing system. The award...
- The National Eye Institute awarded a purchase order to Illumina, Inc. for NextSeq 2000 Silver support service valued at $284,104.48 on January 15, 2022, with ultimate completion on April 14, 2027. The order covers one annual preventive maintenance inspection during the contract period, to be performed by factory-trained, technically qualified personnel at the contractor's San Diego, California location. Pricing is firm fixed-price with no small business set-aside. The order originated from a...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $265,200 purchase order to Illumina, Inc. to deliver one NextSeq 2000 sequencing system, a one-year DRAGEN software license, and installation services. The sequencing system and software will replace aging equipment and reduce costs while enabling continued use of validated protocols to support the Center for Cellular Engineering's research efforts. The single award was made on a non-competitive...
- The National Institutes of Health Clinical Center awarded a $279,999.93 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two NextSeq 1000 Sequencing Systems to replace older equipment. The solicitation sought sequencing systems that could automatically generate DNA clusters and perform sequencing, primary, and secondary analysis compatible with existing assays, reagents, consumables, software, and workflows. As the only vendor...
- This is a firm fixed-price purchase order contract awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $24,714.86 contract covers the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services, to support genomic sequencing and analysis research and diagnostics needs...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $48,209 firm fixed price purchase order to Illumina, Inc. for a service contract to provide a NextSeq 2000 DNA sequencer with serial number VH01190. The single-year contract, valued at forty-eight thousand two hundred nine US dollars, will be performed at the NIH Clinical Center campus located in Bethesda, Maryland through September 2024. Illumina will deliver the requested DNA sequencing...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $25,959 purchase order to Illumina, Inc. to provide a NEXTSEQ 2000 SERVICE AGREEMENT. The contract has a firm fixed price and period of performance from September 29, 2023 through September 28, 2024. The original solicitation sought a service contract for NEXTSEQ 2000 maintenance and support services. As the prime contractor, Illumina will deliver these services for the...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the procurement of an Illumina NextSeq 2000 sequencing system with a trade-in. The total ceiling value of the award is $207,415.25 and the ultimate completion date is October 4, 2024. The contract does not have any set-aside designation. Based on Illumina's background as a manufacturer of genetic and genomic analysis instruments and reagents, this award is likely...
- This is a firm fixed-price purchase order awarded by the National Eye Institute (NEI), a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $76,786.00, is for the procurement of NextSeq2000 reagents to support the agency's next-generation sequencing (NGS) work. Illumina is a for-profit organization and manufacturer of goods, and the contract does not utilize...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...